OMOP May Seek To Partner With Mini-Sentinel On Drug Safety, PCORI On Outcomes Research
The drug industry-funded Observational Medical Outcomes Partnership may seek collaboration with high-profile public-private drug safety and comparative effectiveness research initiatives.
You may also be interested in...
As the Patient-Centered Outcomes Research Institute opens up the public comment period for the draft report created by the institute’s Methodology Committee, criticisms on the direction PCORI is moving are beginning to surface, including accusations that it is becoming just another AHRQ or NIH.
With the recent addition of claims data from two major insurance companies, the FDA postmarketing drug safety surveillance pilot project known as Mini Sentinel has already exceeded its statutory goal of gaining access to electronic health care data for 100 million individuals by July 12, 2012.
With price controls in Medicare looming nine years after approval, launch strategies such as ‘bridge’ programs that build initial volume with free drug may have to be adjusted.